OR WAIT null SECS
July 21, 2025
July 18, 2025
Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.
July 17, 2025
A structured, risk-based framework for pharmaceutical compounding that enhances quality, regulatory compliance, and process consistency.
July 16, 2025
The annual Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.
July 15, 2025
Biodegradable weekly implant delivers stable levodopa levels, aiming to streamline Parkinson’s care while reshaping drug reformulation and delivery strategies.
July 14, 2025
The IL-36 inhibitor is being explored for additional inflammatory skin conditions, aiming to expand treatment options for underserved patient groups.
July 11, 2025
FDA says the move boosts regulatory transparency, offering insights into common approval barriers in drug applications and reducing guesswork.
July 10, 2025
The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.